Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 USD | -4.80% | +14.74% | -9.17% |
Financials (USD)
Sales 2024 * | 1.1B | Sales 2025 * | 1.13B | Capitalization | 120M |
---|---|---|---|---|---|
Net income 2024 * | -83M | Net income 2025 * | 66M | EV / Sales 2024 * | 0.25 x |
Net Debt 2024 * | 156M | Net Debt 2025 * | 402M | EV / Sales 2025 * | 0.46 x |
P/E ratio 2024 * |
-1.42
x | P/E ratio 2025 * |
1.57
x | Employees | 1,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.65% |
Latest transcript on Emergent BioSolutions Inc.
1 day | -4.80% | ||
1 week | +14.74% | ||
Current month | -13.83% | ||
1 month | -14.17% | ||
3 months | +15.96% | ||
6 months | -3.54% | ||
Current year | -9.17% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | Feb. 20 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 18-03-25 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 22-03-31 |
Marvin White
BRD | Director/Board Member | 62 | 10-05-31 |
Louis Sullivan
BRD | Director/Board Member | 90 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 27 M€ | -4.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.18 | -4.80% | 798 395 |
24-04-23 | 2.29 | +6.02% | 860,992 |
24-04-22 | 2.16 | +5.88% | 1,393,297 |
24-04-19 | 2.04 | +9.68% | 936,801 |
24-04-18 | 1.86 | -2.11% | 1,061,154 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.17% | 120M | |
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- EBS Stock